Pricing Log in Create free account
Saturday 17 October 2026 Export RPID’s income statement to Excel — free account

Rapid Micro Biosystems, Inc.

RPID Healthcare Medical Devices

Rapid Micro Biosystems, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $33.6 million, up 19.7% from fiscal 2024. In the quarter to June 2026, revenue grew 10.9%, EPS was flat and free cash flow fell 24.0%, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three.

0.76 0.09 −10.59%
Market cap
$42.4M
P/E
0.0×
Fwd P/E
−2.1×
Dividend yield
—
F-score
3/9
Altman Z
−8.86
Beneish M
−5.06
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total sells 1.14
Totals in millions of $.
Dec 25 Mar 26 Jun 26 Sep 26
Buy — — — — — — — — — — — —
Sell — — 1 7 3 — — — — — — —
Insider Ownership 44.26%

Capital & Financial Ratios $m

Market Cap 42.39
Revenue 35.18
Net Income (51.20)
Free Cash Flow (40.39)
Net Debt (0.63)
Current Ratio 2.55 (at or above 1.5: strong)
Debt/Equity 1.08
P/E ratio 0.00
Fwd P/E (2.14) (negative: loss-making)
P/S ratio 1.04
P/B ratio 2.07
Past 5Y EPS Growth —
This Y EPS Growth 10.24%
Next Y EPS Growth 24.14% (at or above 15%: strong)
Next Y revenue growth 16.95% (at or above 10%: strong)
Next 5Y EPS Growth 23.23% (at or above 15%: strong)

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 1.0×, against a ten-year median of 0.8×; over the ten years it ranged from −3.3× in 2022 to 22.6× in 2021.
P/S against its own 10 years 4.16%
10-year low 10-year high
P/B against its own 10 years 68.98%
10-year low 10-year high

Dividends

Payout Ratio —
Annual Dividend Rate —
Annual Dividend Yield —
total individual payouts
2023 Powerpack
2022 Powerpack
2021 Powerpack
2020 Powerpack
2019 Powerpack
special payouts not included in total or ratios

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 92 51 38 20
Receivables 6 8 3 6
Inventory 20 20 18 19
Other — — — —
120 81 61 46
2023 2024 2025 Q'26
Payables 2 3 4 5
ST’ Debt — — — —
Other — — — —
19 18 18 18

Compound Annual Growth %

10y 5y 3y
Sales — 15.88% 25.15%
Cash Flow — 0.00% 0.00%
Earnings — 0.00% 0.00%
Book Value — 0.00% (41.30%)

Revenue $m

Mar Jun Sep Dec Year
’26 8 8 — — —
’25 7 7 8 11 34
’24 6 7 8 8 28
’23 5 5 6 6 23
’22 4 4 5 4 17
’21 5 6 7 5 23
’20 3 3 5 5 16
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 (15) (13) — — —
’25 (9) (10) (9) (3) (31)
’24 (16) (10) (9) (10) (44)
’23 (17) (9) (10) (9) (45)
’22 (17) (15) (15) (12) (59)
’21 (11) (12) (19) (13) (55)
’20 (8) (9) (9) (5) (31)
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 (15) (12) — — —
’25 (9) (10) (9) (3) (32)
’24 (16) (11) (9) (10) (46)
’23 (17) (9) (10) (10) (47)
’22 (19) (17) (17) (12) (65)
’21 (12) (12) (20) (15) (58)
’20 (8) (9) (9) (5) (32)
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 (0.31) (0.27) — — —
’25 (0.26) (0.27) (0.26) (0.28) (1.05)
’24 (0.31) (0.29) (0.26) (0.22) (1.08)
’23 (0.32) (0.33) (0.31) (0.26) (1.22)
’22 (0.35) (0.31) (0.38) (0.39) (1.43)
’21 (34.48) (20.01) (0.71) (0.35) (3.94)
’20 (22.65) (26.22) (23.78) (30.63) (103.28)
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Trend 2026e 2027e 2028e
Price, $
Price, $ Low — — — — — 9.04 1.12 0.74 0.58 0.91

Analyst estimates 2026–2028

Powerpack
High — — — — — 27.04 11.34 1.55 1.34 4.50
People
People Employees — — — — 160 202 177 193 163 171
Revenue/emp, $m — — — 0.00 0.10 0.12 0.10 0.12 0.17 0.20
Income, $m
Income, $m Revenue — — — 17 16 23 17 23 28 34
Gross margin, % — — — (1.42) (50.20) (33.32) (49.85) (24.36) (0.39) 3.12
EBT — — — (21) (37) (73) (61) (52) (47) (47)
EBT margin, % — — — (125.63) (229.79) (316.09) (358.27) (232.85) (167.08) (140.18)
Net income — 0 — (21) (37) (74) (61) (52) (47) (47)
Depreciation — — — 1 2 2 3 3 3 3
Per share, $
Per share, $ Revenue — — — 47.72 44.78 1.17 0.40 0.52 0.64 0.75
Earnings — — — (61.19) (103.28) (3.94) (1.43) (1.22) (1.08) (1.05)
Cash flow — — — (61.12) (86.34) (2.78) (1.38) (1.05) (1.01) (0.70)
Capex — — — (4.90) (1.92) (0.16) (0.16) (0.04) (0.03) (0.02)
Free cash flow — — — (66.02) (88.26) (2.94) (1.54) (1.09) (1.04) (0.71)
Book value — — — (238.66) (353.78) 11.17 3.87 2.74 1.73 0.74
Shares, m — — — 0 0 20 42 43 44 45
Valuation, ×
Valuation, × P/E — — — 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S — — — 0.69 0.69 9.06 3.02 1.74 1.40 3.86
P/B — — — 0.00 0.00 0.95 0.32 0.33 0.52 3.90
EV/Sales — — — (2.79) (2.79) 0.75 (2.90) (2.06) (0.18) 3.28
EV/FCF — — — 1.59 1.59 (0.30) 0.76 0.99 0.11 (3.45)
Cash, $m
Cash, $m Operating cash flow — — — (21) (31) (55) (59) (45) (44) (31)
Capex — — — (2) (1) (3) (7) (2) (1) (1)
Free cash flow — — — (23) (32) (58) (65) (47) (46) (32)
Balance, $m
Balance, $m Working capital — — — 13 47 200 120 101 63 43
Total debt — — — 18 25 0 7 — — 19
Net debt — — — 5 (20) (193) (101) (92) (51) (19)
Shareholders’ equity — — — (83) (127) 221 164 118 75 33
Returns, %
Returns, % ROA — — — (168.01) (88.94) (50.15) (28.16) (31.41) (38.81) (54.47)
ROIC — — — 0.00 0.00 (105.87) (62.99) (136.30) (126.72) (214.45)
ROE — — — 25.40 43.15 (166.07) (31.58) (37.19) (48.50) (86.82)
Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Rapid Micro Biosystems, Inc. vs peers in Medical Devices (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
MDAI Spectral AI, Inc. $49.6M — (loss-making) — (loss-making) −30.42% (below 0%: shrinking) n/m −21.86% (below 0%: shrinking) 31.58% (122.70%) Compare
TLIS Talis Biomedical Corporation $46.3M — (loss-making) — (loss-making) −94.01% (below 0%: shrinking) n/m +23.80% (above 0%: growing) 91.78% 0.00% Compare
SRTS Sensus Healthcare, Inc. $45.6M — (loss-making) — (loss-making) −68.69% (below 0%: shrinking) n/m −201.65% (below 0%: shrinking) 33.58% (138.86%) Compare
TELA TELA Bio, Inc. $45.6M — (loss-making) — (loss-making) −4.49% (below 0%: shrinking) n/m −17.72% (below 0%: shrinking) 72.77% (48.12%) Compare
SNWV Sanuwave Health Inc. $44.5M 3.0× — (loss-making) −3.13% (below 0%: shrinking) n/m +86.75% (above 0%: growing) 76.23% (2.88%) Compare
XTNT Xtant Medical Holdings, Inc. $42.5M — (loss-making) — (loss-making) −34.96% (below 0%: shrinking) n/m −881.96% (below 0%: shrinking) 57.88% (39.81%) Compare
RPID Rapid Micro Biosystems, Inc. $42.4M — (loss-making) — (loss-making) +10.91% (above 0%: growing) n/m −23.97% (below 0%: shrinking) 15.05% (152.99%)
NNOX Nano-X Imaging Ltd. $38.6M — (loss-making) — (loss-making) +36.71% (above 0%: growing) n/m −21.37% (below 0%: shrinking) (1,050.87%) (1,334.91%) Compare
CVRX CVRx, Inc. $37.0M — (loss-making) — (loss-making) +15.57% (above 0%: growing) n/m −11.18% (below 0%: shrinking) 87.39% (82.92%) Compare
Median of peers $45.0M — — −17.45% — −19.54% 65.33% (65.52%)

All 149 Medical Devices stocks →

Rapid Micro Biosystems, Inc. (RPID) key facts

  • Strength: Rapid Micro Biosystems, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $33.6 million, up 19.7% from fiscal 2024.
  • Rapid Micro Biosystems, Inc. (RPID) is a Medical Devices company in the Healthcare sector, listed on Nasdaq.
  • As of October 16, 2026, RPID traded at $0.76, a market capitalization of $42.4 million.
  • Return on equity was −86.8% and debt-to-equity 1.08.
  • Its Piotroski F-score is 3 out of 9 and its Altman Z-score is −8.86 (distress zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.

Rapid Micro Biosystems, Inc. (RPID) Latest News

No news at this impact. Lower the threshold for more.
stockrow.com/RPID · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com